{"id":9858,"date":"2021-03-15T11:56:38","date_gmt":"2021-03-15T15:56:38","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=9858"},"modified":"2021-03-15T11:56:38","modified_gmt":"2021-03-15T15:56:38","slug":"soleno-therapeutics-inc-slno-subject-of-investigation","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/","title":{"rendered":"Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-9859 size-full\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg\" alt=\"Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses. The investigation concerns potential violations of the federal securities laws.  If you have losses from investing in Soleno Therapeutics, Inc. (SLNO), contact Silver Law Group for a no-cost consultation at (800) 975-4345 or at ssilver@silverlaw.com.  Soleno Therapeutics, formerly known as Capnia Inc., is a clinical stage biopharmaceuticals company that is trying to develop drugs to treat rare diseases. The company\u2019s leading candidate is called Diazoxide Choline Controlled Release (DCCR), which treats Prader-Willi Syndrome (PWS). \u00a0  Soleno Press Release Sends Stock Lower  On March 8, 2021, Soleno put out a press release about the company\u2019s additional analyses submitted to the U.S. Food and Drug Administration (FDA) related to the company\u2019s phase 3 trial for DCCR.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses. The investigation concerns potential violations of the federal securities laws. <a href=\"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/#more-9858\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses. The investigation concerns potential violations of the federal securities laws. Continue reading \u203a<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602],"tags":[],"class_list":["post-9858","post","type-post","status-publish","format-standard","hentry","category-class-action"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation &#8212;<\/title>\n<meta name=\"description\" content=\"Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors to recover losses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation &#8212;\" \/>\n<meta name=\"twitter:description\" content=\"Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors to recover losses.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation &#8212;","description":"Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors to recover losses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/","twitter_card":"summary_large_image","twitter_title":"Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation &#8212;","twitter_description":"Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors to recover losses.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/","url":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/","name":"Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation &#8212;","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg","datePublished":"2021-03-15T15:56:38+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Soleno Therapeutics, Inc. (SLNO) is being investigated by Silver Law Group regarding potential claims for investors to recover losses.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/03\/Soleno-Therapeutics-Inc.-SLNO.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/soleno-therapeutics-inc-slno-subject-of-investigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Soleno Therapeutics, Inc. (SLNO) Subject Of Investigation"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=9858"}],"version-history":[{"count":1,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9858\/revisions"}],"predecessor-version":[{"id":9860,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9858\/revisions\/9860"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=9858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=9858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=9858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}